Today in News History
On July 12, several notable moments in the history of News stand out. In 1754, Thomas Bowdler, English physician and philanthropist (died 1825) was born. In 1789, Jacques Necker is dismissed as France's Finance Minister sparking the Storming of the Bastille. In 1893, A revolution led by the liberal general and politician José Santos Zelaya takes over state power in Nicaragua. In 1944, Michael Levy, Baron Levy, English philanthropist was born. In 1950, Pakistan joins the International Monetary Fund and the International Bank. In 1960, Congo Crisis: The State of Katanga breaks away from the Democratic Republic of the Congo. In 1961, Antony Jenkins, English banker and businessman was born. In 2007, Ed Mirvish, American-Canadian businessman and philanthropist, founded Honest Ed's (born 1914) passed away. In 2013, Emik Avakian, Iranian-American inventor (born 1923) passed away. In 2015, André Leysen, Belgian businessman (born 1927) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.
Narrative Analysis: Bandwagon
This pre-commercial biotech is worth more than some drugmakers that generate consistent sales.
Narrative Intelligence Brief
This article was published by The Motley Fool, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. In this specific piece, our systems detected the potential use of the "Bandwagon" technique. This narrative approach is often used to shape reader perception by highlighting specific emotional or rhetorical angles. By understanding the editorial perspective of The Motley Fool, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The Motley Fool
July 12, 2026
The Monday Blues. Is the Dip in Monday.com Stock a Buying Opportunity?
July 12, 2026
Is Bitcoin a Good Crypto for Long-Term Investors?
July 12, 2026
XRP Has Pulled Back Sharply. Is Now the Time to Load Up?
July 12, 2026
Jensen Huang's Blue-Collar Millionaire Prediction Lifted Quanta Services' Backlog to $48 Billion
July 12, 2026
Don't Be Misled: Common Myths About Index Funds Debunked
Reliability Insights
P
Technique: Bandwagon
System analysis detected use of specific narrative techniques in this piece.Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"argentina"
Maxi Rodríguez se rinde ante Mikel Merino por su gran actuación con España | Hoy en el Mundial
Argentina Women’s Youth National Team Coach Accused of Sexual Harassment
Argentina's Antonio Rattín Dies; 1966 World Cup Dismissal Led To Red & Yellow Cards
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 33%
Center 0%
Right 67%
The Motley Fool
· Jun 30, 2026
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
AbbVie knows how to plan ahead.
NaturalNews.com
· Jun 28, 2026
Antibiotic resistance and E. coli: The hidden crisis fueling inflammatory bowel disease
(NaturalNews) The reckless overuse of broad-spectrum antibiotics, driven by Big Pharma's profit motive and corruption within medical and agricultural systems, h...
The Next Web
· Jun 30, 2026
After Harvey, vertical AI’s next $10B winner might be in agriculture
In legal, Harvey crossed an 11 billion valuation and Legora is racing to claim the European market behind it. In healthcare, Abridge has built a multi-billion-dollar business turning clinical conversations into structured medical records. In customer service, Sierra is now valued at over 15 billion, making it one of the fastest companies in AI history [] This story continues at The Next Web
Tampa Free Press
· Jul 10, 2026
Why Codifying Most Favored Nation Drug Pricing Would Be A Mistake
America’s drug pricing crisis is real. Patients skip doses, seniors split pills, and employers shoulder rising health costs year after year. That frustration has made the idea of Most Favored Nation drug pricing politically attractive: if other wealthy countries pay less, why shouldn’t the United States? The problem is that codifying MFN into law would [] Why Codifying Most Favored Nation Drug Pricing Would Be A Mistake
Seeking Alpha
· Jun 22, 2026
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition
The Hindu BusinessLine
· Jun 23, 2026
IT selloff drags Nifty below 24,000; pharma stocks buck the trend
Pharma bucked the broader trend and remained the standout performer of the session. Cipla led gains on the Nifty 50, rising 2.56 per cent to 1,452 with over 37.20 lakh shares traded worth 53,831.39 lakh
Topics:
Related coverage for "Revolution Medicines Has a $40 Billion Market Cap and Generates No Revenue. Here's Why That's Not Absurd.": The Motley Fool — This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?. NaturalNews.com — Antibiotic resistance and E. coli: The hidden crisis fueling inflammatory bowel disease. The Next Web — After Harvey, vertical AI’s next $10B winner might be in agriculture. Tampa Free Press — Why Codifying Most Favored Nation Drug Pricing Would Be A Mistake. Seeking Alpha — AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition. The Hindu BusinessLine — IT selloff drags Nifty below 24,000; pharma stocks buck the trend